MedTrace Logo

Examination of the Lipid Metabolism of the Liver After Choline Substitution in Cystic Fibrosis

NCT03312140 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2017-11-30

No results posted yet for this study

Summary

Pilot study to investigate the effect of choline chloride in cystic fibrosis patients with liver steatosis by comparing their status before and after the intervention

Conditions

  • Cystic Fibrosis Liver Disease

Interventions

DRUG

Choline Chloride

Sponsors & Collaborators

  • University Hospital Tuebingen

    lead OTHER

Principal Investigators

  • Joachim Riethmüller, PD · Klinik für Kinder- und Jugendmedizin Tübingen

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-06
Primary Completion
2016-04-24
Completion
2017-02-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03312140 on ClinicalTrials.gov